@drsthanus Interesting case. Unfortunate that a healthy young person had a screening chest x ray for no reason and was then subjected to multiple studies which cost thousands of dollars, patient time and probably anxiety, and subjected her to ionizing radiation!
@IM_Crit_ I love this account and love these points! Unless I’m missing something, you may have linked to a paper on extubating to HHFNC 40 LPM vs 60 LPM. I think the followers would benefit from being directed to the gastric suctioning paper if you had it handy. Thanks.
Learned so much about qualitative methodologies 🧠and critical care communication 🗣️ from incredible mentors @JudithBVick@DeepAshanaMD in this project.
Give it a read for insights on shared decision-making and prognostic (mis)-understanding in the ICU!
https://t.co/77239R0S8k
For long-term oxygen therapy, is 24 hours a day better than 15? Not according to a randomized trial of supplemental oxygen for patients with severe resting hypoxemia. https://t.co/E8jFVsg1PA
#MedTwitter@BageLeMage@NEJM
Did my first PA catheter (🦢!) of fellowship last week, and trying to stern one the wedge, I couldn’t agree more with these authors:
“This Patient Needs a Doctor, Not a Guideline!” The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement https://t.co/s1Hs5PmLUW
It was great to meet with @DukeMedicine residents to discuss local health and climate priorities.
I'm proud to be your partner in Washington as we continue to prioritize urgently needed climate conservation, green energy, and health-related legislation in Congress.
Had a blast at #SCCM2024 learning from colleagues around the 🌎 and presenting our work on shared decision-making and prognostic understanding in the ICU 🫁🫀
Huge thanks to my ⭐️ mentors and co-authors @DeepAshanaMD and @JudithBVick
Excited to share our case report in @bmj_latest of an extraordinary response to BAT plus immunotherapy in a man with CHEK2 mutated mCRPC including his testimonial! @DukeGUCancer@MattLabsMD@EAntonarakis by Ben Berger! https://t.co/4BdmtAtWLa
Check out our perspective on systemic therapy for recurrent mRCC after treatment with adjuvant pembrolizumab, led by rising star @BenBoyga of @IMResidencyDuke!
Came across this gem from @ABIMFoundation today. All patients should be empowered to ask these questions. I hope I can train to answer them. #ChoosingWisely